Gal-3 can be a pharmacological target in endometriosis treatment
Gal-3 plays a role in development and maintenance of endometriosis
Key Points Lay Summary
Estrogen Receptor Signaling and Endometriosis-Associated Ovarian Cancer
The gene expression pattern in EAOC is more consistent with endocrine resistance
Key Points Lay Summary
Factors Affecting Women’s Choices to Enter Clinical Trials
Results are based on the findings of a study that analyzed women who participated in the PRE-EMPT clinical trial.
Key Points Lay Summary
Immunologic Disorder in the Progression of Endometriosis
What’s happening in the peritoneal microenvironment of the endometriosis patients?
Key Points Lay Summary
The miscarriage rate in women with endometriosis undergoing IVF fresh cycles
There is no statistically significant increase regarding the risk of miscarriage in women with endometriosis who achieved pregnancy through IVF fresh cycles.
Key Points Lay Summary
The duration of impairment of ovarian reserve after laparoscopic surgery
Effect of laparoscopic endometrioma removal on anti-mullerian hormone levels.
Key Points Lay Summary
A link between endometrioid ovarian carcinoma and endometriosis.
Unfolded protein response (UPR) neutralizes the apoptotic stimulus in cancer cells.
Key Points Lay Summary
Long non‐coding RNA, Epithelial mesenchymal transition, and Endometriosis
Long non‐coding RNA AFAP1‐AS1 promoting the epithelial-mesenchymal transition of endometriosis is correlated with transcription factor ZEB1
Key Points Lay Summary